NSB 7.14% 3.8¢ neuroscientific biopharmaceuticals ltd

Ann: Positive results in biomarker characterisation of Emtins, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,086 Posts.
    lightbulb Created with Sketch. 2476
    Yes, definitely a bit yawny. This news is part of the long-game thread.

    And given how slowly the company is creeping forward with the main game, the long game is probably going to be of more interest to the beneficiaries of my estate.

 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.